Posts

Friday Five: Freenome's CRC Test Wins FDA Nod

on

J&J pays Sail $785M, charting course to possible in vivo CAR-T buyout

on

BMS CEO Boerner Says No Compulsion to Chase Deals Despite Quiet M&A Year

on

Pfizer advances Litfulo for vitiligo in face of Incyte and AbbVie competition

on

FTC sues Hims & Hers over data privacy and deceptive billing practices

on

Doctronic acquires Summer Health to expand into pediatric care

on

VoxNeuro Gains FDA 510(k) Clearance for Cognitive Function Neuroimaging (cfNI) Software

on

Recent Biotech Reverse Mergers Accelerate BTK‑Based Immune & Inflammatory Drug Programs

on

Relation Deepens GSK AI Pact With Up to $110M Deal Aiming at Transformationally Different Success Rates in Drug Discovery

on

Caldera snaps up Synlogic in reverse merger to hit Nasdaq and fund IBD pipeline through 2029

on

AbbVie scores dual EU approvals for Rinvoq in vitiligo, alopecia

on

Insilico Medicine Receives FDA Fast Track Designation for AI-Driven Pan-TEAD Inhibitor ISM6331 in Advanced Mesothelioma

on

ThinkSono Receives FDA Clearance for Ultrasound AI Software for Blood Clots

on